| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.7M | +1794.0% |
| Cost of Revenue | $6.5M | +839.9% |
| Gross Profit | $6.2M | — |
| R&D Expense | $11.5M | -44.3% |
| SG&A Expense | $77.9M | +53.0% |
| Operating Income | -$83.2M | -16.4% |
| Pre-tax Income | -$106.3M | -38.9% |
| Income Tax | $0 | -100.0% |
| Net Income | -$106.3M | -38.9% |
| EPS (Basic) | -$4.53 | +13.7% |
| EPS (Diluted) | -$4.53 | +13.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.7M | -31.2% |
| Accounts Receivable | $7.4M | +450.6% |
| Inventory | $8.4M | +198.4% |
| Current Assets | $79.8M | -15.6% |
| Total Assets | $88.5M | -9.6% |
| Current Liabilities | $22.2M | +38.9% |
| Long-term Debt | $48.1M | +63.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.6M | -41.1% |
| Capital Expenditures | $1.4M | +237.5% |
| Investing Cash Flow | -$1.4M | -237.5% |
| Financing Cash Flow | $67.5M | -54.4% |
| Free Cash Flow | -$95.0M | -42.3% |
| Total Liabilities |
| $132.7M |
| +192.3% |
| Stockholders' Equity | -$44.2M | -184.1% |